Report overview
Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.
This report contains market size and forecasts of Injectable Drug Delivery Devices in global, including the following market information:
Global Injectable Drug Delivery Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Drug Delivery Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Injectable Drug Delivery Devices companies in 2021 (%)
The global Injectable Drug Delivery Devices market was valued at 8725.7 million in 2021 and is projected to reach US$ 14720 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Drug Delivery Devices include Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo, Antares Pharma and Novo Nordik, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Drug Delivery Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Drug Delivery Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Drug Delivery Devices Market Segment Percentages, by Type, 2021 (%)
Devices
Formulation
Global Injectable Drug Delivery Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Drug Delivery Devices Market Segment Percentages, by Application, 2021 (%)
Immune Disorder
Cancer
Diabetes
Others
Global Injectable Drug Delivery Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Drug Delivery Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Drug Delivery Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Drug Delivery Devices revenues share in global market, 2021 (%)
Key companies Injectable Drug Delivery Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Injectable Drug Delivery Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dickinson and Company
Baxter International
Schott
Eli Lilly
Pfizer
Gerresheimer
Terumo
Antares Pharma
Novo Nordik
Sanofi
Unilife
Zogenix
Hospira
Presage Bioscience
MicroCHIPS
Pearl Therapeutics
Genentech
Bend Research
